{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:10:00Z","timestamp":1790813400021,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Lung cancer is the most common malignancy in humans and the leading cause of cancer-related deaths worldwide. Nonsmall cell lung cancer (NSCLC), the primary histologic type, is categorized into lung adenocarcinoma (LUAD) and lung squamous cell carcinoma based on immunohistochemical thyroid transcription factor-1 and P40 status. LUAD is morphologically classified into five histological subtypes, based on physician experience, which can lead to confusion among pathologists and clinicians. Histological subtypes serve as crucial markers for lung cancer development and hold significant clinical value for cancer diagnosis, prognosis, and treatment response prediction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>Identifying the various subtypes of NSCLC has become pivotal for enhancing diagnostic standards and patient prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results:<\/jats:title>\n                    <jats:p>In this study, we proposed a novel classification of NSCLC tissues into five subtypes (bronchial epithelial carcinoma, bronchiolar alveolar carcinoma, alveolar cell carcinoma, secretory adenocarcinoma, and mucinous adenocarcinoma) based on tissue origin. Furthermore, mRNA chip screening and next-generation sequencing revealed that these five subtypes exhibit distinct gene expression patterns and mutation signatures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study proposes a novel NSCLC classification model designed to incorporate gene signatures into tissue origin-based histopathological subtypes, complementing the World Health Organization classification, and enhancing both diagnostic accuracy and clinical practicability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2333_24","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:00:56Z","timestamp":1779951656000},"page":"334-342","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Association between tissue origin classification and the clinical features and molecular phenotypes of nonsmall cell lung cancer"],"prefix":"10.4103","volume":"22","author":[{"given":"Ping","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Shandong Institute of Nephrology, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Shandong Institute of Nephrology, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Shandong Institute of Nephrology, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Binzhou Medical University Hospital, Binzhou, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Shandong Institute of Nephrology, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangpeng","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Shandong Institute of Nephrology, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Shandong Institute of Nephrology, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shandong Second Provincial General Hospital, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Linyi People\u2019s Hospital, Linyi, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Shandong Institute of Nephrology, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20260528","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020: Epidemiology, etiology, and prevention","volume":"41","author":"Bade","year":"2020","journal-title":"Clin Chest Med"},{"key":"R2-20260528","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R3-20260528","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"R4-20260528","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: Impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"R5-20260528","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"R6-20260528","doi-asserted-by":"crossref","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ettinger","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"R7-20260528","first-page":"39","article-title":"The 2015 World Health Organization classification of lung tumors: New entities since the 2004 Classification","volume":"110","author":"Mengoli","year":"2018","journal-title":"Pathologica"},{"key":"R8-20260528","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccm.2019.11.001","article-title":"Lung cancer pathology: Current concepts","volume":"41","author":"Travis","year":"2020","journal-title":"Clin Chest Med"},{"key":"R9-20260528","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345245","article-title":"p40: A p63 isoform useful for lung cancer diagnosis \u2013A review of the physiological and pathological role of p63","volume":"57","author":"Nobre","year":"2013","journal-title":"Acta Cytol"},{"key":"R10-20260528","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/JOC.JOC_252_16","article-title":"Immunoexpression of TTF1 and p63 differentiates lung adenocarcinomas in sputum samples","volume":"38","author":"Veena","year":"2021","journal-title":"J Cytol"},{"key":"R11-20260528","first-page":"81","article-title":"The value of cytokeratin 5\/6, p63 and thyroid transcription factor-1 in adenocarcinoma, squamous cell carcinoma and non-small-cell lung cancer of the lung","volume":"31","author":"Argon","year":"2015","journal-title":"Turk Patoloji Derg"},{"key":"R12-20260528","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5858\/arpa.2011-0232-OA","article-title":"Evaluation of napsin A, cytokeratin 5\/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung","volume":"136","author":"Whithaus","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R13-20260528","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40169-015-0057-2","article-title":"Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5\/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: A retrospective study of 246 fine needle aspiration cases","volume":"4","author":"Gurda","year":"2015","journal-title":"Clin Transl Med"},{"key":"R14-20260528","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R15-20260528","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00408-020-00407-5","article-title":"Update 2020: Management of non-small cell lung cancer","volume":"198","author":"Alexander","year":"2020","journal-title":"Lung"},{"key":"R16-20260528","doi-asserted-by":"crossref","first-page":"e32899","DOI":"10.1097\/MD.0000000000032899","article-title":"Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment","volume":"102","author":"Alduais","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R17-20260528","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4103\/jcrt.jcrt_108_25","article-title":"Improvement and application of supine position components for lung tumor microwave ablation","volume":"21","author":"Zhang","year":"2025","journal-title":"J Cancer Res Ther"},{"key":"R18-20260528","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4103\/jcrt.JCRT_187_19","article-title":"Role of immunohistochemistry markers in neoplastic lung lesions","volume":"17","author":"Umakanthan","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"R19-20260528","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00000478-200206000-00010","article-title":"TTF-1 expression in pulmonary adenocarcinomas","volume":"26","author":"Yatabe","year":"2002","journal-title":"Am J Surg Pathol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2333_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:39:20Z","timestamp":1787845160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2333_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2333_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2024-12-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}